• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血压对抗高血压治疗反应的年龄依赖性:关于五种β-肾上腺素能受体拮抗剂在不同实验条件下的一些方法学考量与观察

Age dependency of blood pressure response to antihypertensive treatment: some methodological considerations and observations on five beta-adrenoceptor antagonists under different experimental conditions.

作者信息

Man in 't Veld A J, van den Meiracker A H, Schalekamp M A

机构信息

Department of Internal Medicine I, University Hospital Dijkzigt, Erasmus University Rotterdam, The Netherlands.

出版信息

J Cardiovasc Pharmacol. 1988;12 Suppl 8:S93-9.

PMID:2469907
Abstract

Patient selection, trial design, methodology of blood pressure measurement, experimental conditions, and methods of statistical analysis may be all determinants of real or spurious relationships in clinical hypertension research. Our study of 52 hypertensive subjects, in which we analyzed acute and long-term treatment responses, does not demonstrate an age dependency of blood pressure response to treatment with beta-adrenoceptor antagonists.

摘要

患者选择、试验设计、血压测量方法、实验条件以及统计分析方法可能都是临床高血压研究中真实或虚假关系的决定因素。我们对52名高血压患者进行了研究,分析了急性和长期治疗反应,结果并未显示血压对β-肾上腺素能受体拮抗剂治疗的反应存在年龄依赖性。

相似文献

1
Age dependency of blood pressure response to antihypertensive treatment: some methodological considerations and observations on five beta-adrenoceptor antagonists under different experimental conditions.血压对抗高血压治疗反应的年龄依赖性:关于五种β-肾上腺素能受体拮抗剂在不同实验条件下的一些方法学考量与观察
J Cardiovasc Pharmacol. 1988;12 Suppl 8:S93-9.
2
The gain-of-function G389R variant of the beta1-adrenoceptor does not influence blood pressure or heart rate response to beta-blockade in hypertensive subjects.β1肾上腺素能受体的功能获得性G389R变体不影响高血压患者对β受体阻滞剂的血压或心率反应。
Clin Sci (Lond). 2000 Sep;99(3):233-8.
3
Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.尼日利亚一家三级医院高血压药物治疗的趋势变化:对新旧抗高血压药物的疗效、安全性、合理性和药物经济学的真实世界评估
J Hum Hypertens. 2003 Apr;17(4):277-85. doi: 10.1038/sj.jhh.1001538.
4
Determinants of exaggerated difference in morning and evening blood pressure measured by self-measured blood pressure monitoring in medicated hypertensive patients: Jichi Morning Hypertension Research (J-MORE) Study.通过自我测量血压监测法测量的药物治疗高血压患者早晚血压差异过大的决定因素:秩父晨峰高血压研究(J-MORE)
Am J Hypertens. 2005 Jul;18(7):958-65. doi: 10.1016/j.amjhyper.2005.01.013.
5
Discordant beta-blocker effects on clinic, ambulatory, resting, and exercise hemodynamics in patients with hypertension.β受体阻滞剂对高血压患者临床、动态、静息及运动血流动力学的不同影响。
Pharmacotherapy. 2006 Sep;26(9):1247-54. doi: 10.1592/phco.26.9.1247.
6
Effects of nitroxazepine on diastolic blood pressure in mild hypertensive patients--a short term clinical study.硝唑西泮对轻度高血压患者舒张压的影响——一项短期临床研究。
Indian J Physiol Pharmacol. 1995 Jul;39(3):293-5.
7
Age and responses to isometric exercise in hypertension: possible predictors of the antihypertensive effect of diuretics and beta-blockers.年龄与高血压患者等长运动反应:利尿剂和β受体阻滞剂降压效果的可能预测因素
Int J Clin Pharmacol Ther Toxicol. 1985 Oct;23(10):554-9.
8
[Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].[原发性高血压患者治疗后昼夜血压及影响因素分析]
Zhonghua Liu Xing Bing Xue Za Zhi. 2004 Aug;25(8):710-4.
9
Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.高血压左心室肥厚患者氯沙坦干预降低终点事件(LIFE)研究中的血压降低及降压药物使用情况
Curr Med Res Opin. 2007 Feb;23(2):259-70. doi: 10.1185/030079906X162854.
10
[After pharmacologic blood pressure treatment: only two in ten male hypertensive patients attain the recommended diastolic pressure].
Lakartidningen. 1988 Jun 1;85(22):1986-7.

引用本文的文献

1
The effect of antihypertensive treatment on the quality of later years.降压治疗对晚年生活质量的影响。
Drugs Aging. 1993 Jan-Feb;3(1):26-39. doi: 10.2165/00002512-199303010-00003.
2
Ketanserin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in hypertension and peripheral vascular disease.酮色林。对其药效学和药代动力学特性以及在高血压和外周血管疾病中的治疗潜力的综述。
Drugs. 1990 Dec;40(6):903-49. doi: 10.2165/00003495-199040060-00010.
3
Choosing the optimum therapy for older hypertensive patients.
为老年高血压患者选择最佳治疗方法。
Drugs Aging. 1991 Jan;1(1):36-47. doi: 10.2165/00002512-199101010-00005.